Clinical epidemiology of HIV-associated end-stage renal failure in the UK

AIDS

Volumn 23, Issue 18, 2009, Pages 2517-2521

  Bansi, Loveleen ^a   Hughes, Amelia ^b   Bhagani, Sanjay ^c   MacKie, Nicola E ^d   Leen, Clifford ^e   Levy, Jeremy ^d   Edwards, Simon ^a   Connolly, John ^c   Holt, Steve G ^f   Hendry, Bruce M ^g,h   Sabin, Caroline ^a   Post, Frank A ^g,h  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Chelsea and Westminster NHS Trust   (United Kingdom)

^c ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^d IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^e NHS LOTHIAN   (United Kingdom)

^f Worthing Hospital   (Australia)

^g KING S COLLEGE HOSPITAL   (United Kingdom)

^h KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Dialysis; Highly active antiretroviral therapy; HIV; Kidney; Renal failure

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RACE DIFFERENCE; RENAL REPLACEMENT THERAPY; RISK FACTOR; RISK REDUCTION; SURVIVAL RATE; UNITED KINGDOM; VIRUS LOAD;

ADULT; AIDS-ASSOCIATED NEPHROPATHY; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; GREAT BRITAIN; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PREVALENCE; VIRAL LOAD;

EID: 72949083506     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283320e12     Document Type: Article

References (15)

1. Winston JA, Burns GC, Klotman PE. The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy. Semin Nephrol 1998; 18:373-377.
2. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM. Racial differences in end-stage renal disease rates in HIV infection versus diabetes. J Am Soc Nephrol 2007; 18:2968-2974.
3. Szczech LA, Gupta SK, Habash R, et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004; 66:1145-1152.
4. Haas M, Kaul S, Eustace JA. HIV-associated immune complex glomerulonephritis with 'lupus-like' features: a clinicopatho-logic study of 14 cases. Kidney Int 2005; 67:1381-1390.
5. Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS 2004; 18:541-546.
6. Lucas GM, Mehta SH, Atta MG, et al. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS 2007; 21:2435-2443.
7. Atta MG, Fine DM, Kirk GD, Mehta SH, Moore RD, Lucas GM. Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland. Clin Infect Dis 2007; 45:1625-1632.
8. Rodriguez RA, Mendelson M, O'Hare AM, Hsu LC, Schoenfeld P. Determinants of survival among HIV-infected chronic dialysis patients. J Am Soc Nephrol 2003; 14:1307-1313.
9. Trullas JC, Barril G, Cofan F, et al. Prevalence and clinical characteristics of HIV type 1-infected patients receiving dialysis in Spain: results of a Spanish survey in 2006: GESIDA 48/05 study. AIDS Res Hum Retroviruses 2008; 24:1229-1235.
10. Tourret J, Tostivint I, du Montcel ST, et al. Outcome and prognosis factors in HIV-infected hemodialysis patients. Clin J Am Soc Nephrol 2006; 1:1241-1247.
11. Post FA, Campbell LJ, Hamzah L, et al. Predictors of renal outcome in HIV-associated nephropathy. Clin Infect Dis 2008; 46:1282-1289. http://www.hpa.org.uk/hivuk2008.
12. The creation of a large UK-based multicentre cohort of HIV-infected individuals: The UK Collaborative HIV Cohort (UK CHIC) Study. HIV Med 2004; 5:115-124.
13. Gupta SK, Eustace JA, Winston JA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005; 40:1559-1585. http://www.hpa.org.uk/web/HPAwebFile/HPAweb-C/122148/ 2342683. http://www.renalreg.com/reports/renal-registry-reports/2008/.
14. Atta MG, Gallant JE, Rahman MH, et al. Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol Dial Transplant 2006; 21:2809-2813.
15. Roe J, Campbell LJ, Ibrahim F, Hendry BM, Post FA. HIV care and the incidence of acute renal failure. Clin Infect Dis 2008; 47:242-249.